<DOC>
	<DOCNO>NCT01830491</DOCNO>
	<brief_summary>The aim study demonstrate combination therapy aspirin clopidogrel napadisilate inferior aspirin clopidogrel bisulfate respect effectiveness inhibit platelet aggregation , give four week Coronary Artery Disease ( CAD ) patient treat drug-eluting stent &gt; 12 month remain stable condition single antiplatelet agent , aspirin .</brief_summary>
	<brief_title>Comparison Effect &amp; Safety Clopidogrel Napadisilate With Clopidogrel Bisulfate Coronary Artery Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>age 20 80 year men woman coronary artery disease treat drugeluting stent placement &gt; 12 month patient remain stable condition single antiplatelet agent , aspirin patient show sign symptom worsen angina within last six month require coronary artery intervention , coronary artery bypass , coronary angiography Patients take another antiplatelet anticoagulant drug clopidogrel , warfarin , cilostazol addition aspirin , unless could withdraw drug/s , case could enrol study twoweek washout period Patients suffer drug abuse alcohol addiction hypersensitivity clopidogrel aspirin severe liver disease ( ALT AST â‰¥ 10 time upper normal limit ) active hemorrhage gastrointestinal ulcer intracranial hemorrhage high risk bleeding ( blood coagulation disorder , uncontrolled severe hypertension , active bleeding , history severe bleeding ) pregnant lactate woman woman childbearing potential use appropriate contraception method medical mental contraindication study treatment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>